+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

From
Glabellar Lines - Pipeline Insight, 2025 - Product Thumbnail Image

Glabellar Lines - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
Epigenetics Market Report 2025 - Product Thumbnail Image

Epigenetics Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Orphan Drugs Market 2024-2028 - Product Thumbnail Image

Orphan Drugs Market 2024-2028

  • Report
  • August 2024
  • 180 Pages
  • Global
From
From
Dysmenorrhea Market Report and Forecast 2024-2032 - Product Thumbnail Image

Dysmenorrhea Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Aesthetic Medicine Market Report 2025 - Product Thumbnail Image

Aesthetic Medicine Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Nanotechnology in Medicine - Thematic Research - Product Thumbnail Image

Nanotechnology in Medicine - Thematic Research

  • Report
  • May 2022
  • 32 Pages
  • Global
From
Loading Indicator